551 related articles for article (PubMed ID: 18468562)
1. The role of cocrystals in pharmaceutical science.
Shan N; Zaworotko MJ
Drug Discov Today; 2008 May; 13(9-10):440-6. PubMed ID: 18468562
[TBL] [Abstract][Full Text] [Related]
2. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.
Blagden N; de Matas M; Gavan PT; York P
Adv Drug Deliv Rev; 2007 Jul; 59(7):617-30. PubMed ID: 17597252
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical cocrystals: an overview.
Qiao N; Li M; Schlindwein W; Malek N; Davies A; Trappitt G
Int J Pharm; 2011 Oct; 419(1-2):1-11. PubMed ID: 21827842
[TBL] [Abstract][Full Text] [Related]
4. Screening for cocrystallization tendency: the role of intermolecular interactions.
He G; Jacob C; Guo L; Chow PS; Tan RB
J Phys Chem B; 2008 Aug; 112(32):9890-5. PubMed ID: 18646803
[TBL] [Abstract][Full Text] [Related]
5. The A to Z of pharmaceutical cocrystals: a decade of fast-moving new science and patents.
Almarsson Ö; Peterson ML; Zaworotko M
Pharm Pat Anal; 2012 Jul; 1(3):313-27. PubMed ID: 24236844
[TBL] [Abstract][Full Text] [Related]
6. An overview of pharmaceutical cocrystals as intellectual property.
Trask AV
Mol Pharm; 2007; 4(3):301-9. PubMed ID: 17477544
[TBL] [Abstract][Full Text] [Related]
7. Benefits of cocrystallisation in pharmaceutical materials science: an update.
Friščić T; Jones W
J Pharm Pharmacol; 2010 Nov; 62(11):1547-59. PubMed ID: 21039540
[TBL] [Abstract][Full Text] [Related]
8. Characterization and Quality Control of Pharmaceutical Cocrystals.
Izutsu KI; Koide T; Takata N; Ikeda Y; Ono M; Inoue M; Fukami T; Yonemochi E
Chem Pharm Bull (Tokyo); 2016 Oct; 64(10):1421-1430. PubMed ID: 27319284
[TBL] [Abstract][Full Text] [Related]
9. Selecting and controlling API crystal form for pharmaceutical development--strategies and processes.
Yin SX; Grosso JA
Curr Opin Drug Discov Devel; 2008 Nov; 11(6):771-7. PubMed ID: 18946842
[TBL] [Abstract][Full Text] [Related]
10. Physical stability enhancement of theophylline via cocrystallization.
Trask AV; Motherwell WD; Jones W
Int J Pharm; 2006 Aug; 320(1-2):114-23. PubMed ID: 16769188
[TBL] [Abstract][Full Text] [Related]
11. The role of co-crystals in pharmaceutical design.
Steed JW
Trends Pharmacol Sci; 2013 Mar; 34(3):185-93. PubMed ID: 23347591
[TBL] [Abstract][Full Text] [Related]
12. Advanced methodologies for cocrystal synthesis.
Douroumis D; Ross SA; Nokhodchi A
Adv Drug Deliv Rev; 2017 Aug; 117():178-195. PubMed ID: 28712924
[TBL] [Abstract][Full Text] [Related]
13. Crystal Engineering of Pharmaceutical Cocrystals in the Discovery and Development of Improved Drugs.
Bolla G; Sarma B; Nangia AK
Chem Rev; 2022 Jul; 122(13):11514-11603. PubMed ID: 35642550
[TBL] [Abstract][Full Text] [Related]
14. Integration of active pharmaceutical ingredient solid form selection and particle engineering into drug product design.
Ticehurst MD; Marziano I
J Pharm Pharmacol; 2015 Jun; 67(6):782-802. PubMed ID: 25677227
[TBL] [Abstract][Full Text] [Related]
15. Expanding the scope of crystal form evaluation in pharmaceutical science.
Peterson ML; Hickey MB; Zaworotko MJ; Almarsson O
J Pharm Pharm Sci; 2006; 9(3):317-26. PubMed ID: 17207415
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical cocrystals and poorly soluble drugs.
Thakuria R; Delori A; Jones W; Lipert MP; Roy L; Rodríguez-Hornedo N
Int J Pharm; 2013 Aug; 453(1):101-25. PubMed ID: 23207015
[TBL] [Abstract][Full Text] [Related]
17. Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids.
Childs SL; Chyall LJ; Dunlap JT; Smolenskaya VN; Stahly BC; Stahly GP
J Am Chem Soc; 2004 Oct; 126(41):13335-42. PubMed ID: 15479089
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical cocrystals: walking the talk.
Bolla G; Nangia A
Chem Commun (Camb); 2016 Jun; 52(54):8342-60. PubMed ID: 27278109
[TBL] [Abstract][Full Text] [Related]
19. [Progress in the research of amorphous pharmaceuticals].
Ying J; Lü Y; Du GH
Yao Xue Xue Bao; 2009 May; 44(5):443-8. PubMed ID: 19618716
[TBL] [Abstract][Full Text] [Related]
20. Multicomponent Pharmaceutical Cocrystals: A Novel Approach for Combination Therapy.
Srivastava D; Fatima Z; Kaur CD
Mini Rev Med Chem; 2018; 18(14):1160-1167. PubMed ID: 29512461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
